Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
Stanford University
Stanford University
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
Eisai Inc.
Jonsson Comprehensive Cancer Center
SAPU NANO (US) LLC
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
University of Wisconsin, Madison
National Cancer Institute (NCI)
ITM Solucin GmbH
University of Miami
Imperial College London
Novelty Nobility, Inc.
Sichuan Baili Pharmaceutical Co., Ltd.
RayzeBio, Inc.
Stanford University
Jonsson Comprehensive Cancer Center
Case Comprehensive Cancer Center
National Institutes of Health Clinical Center (CC)
Peking University Cancer Hospital & Institute
Nuvation Bio Inc.
Orano Med LLC
Erasmus Medical Center
Legend Biotech USA Inc
Harbour BioMed (Guangzhou) Co. Ltd.